Please contact us for more information or to learn if you are eligible to participate.
The primary objective is to evaluate the efficacy of different doses of NST-4016 on the resolution of NASH without worsening of fibrosis.
Fernando Membreno, MD
NorthSea Therapeutics B.V.
Type of Trial